MTD acquires Ypsomed’s pen needle and BGM businesses, strengthening its leading position in diabetes care

Posted on by

MILAN, March 27, 2024 /PRNewswire/ — MTD (Medical Technology and Devices), a leading provider of medical technology solutions for self-care and professional use worldwide, announces the acquisition Ypsomed’s pen needle and blood glucose monitoring (BGM) businesses. This strategic move…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.